Home › Schizophrenia › Illinois › Naperville
Schizophrenia clinical trials in Naperville, IL
3 studies for Schizophrenia are looking for participants at sites in and around Naperville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
RecruitingPhase 3
- Baber Research Group, Naperville
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
RecruitingObservational study
- Amr Conventions Research - Illinois, Warrenville · 3 mi away
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
RecruitingPhase 4
- Neurocrine Clinical Site, Naperville
About Schizophrenia
Schizophrenia is a serious brain illness that can include hearing voices that aren't there and thinking others are trying to hurt them.
More about Schizophrenia on MedlinePlus
Schizophrenia trials in other cities
- Atlanta, GA21 studies
- Chicago, IL20 studies
- Little Rock, AR18 studies
- San Diego, CA15 studies
- Houston, TX14 studies
- Boston, MA14 studies
- Hollywood, FL14 studies
- Hialeah, FL13 studies
- Austin, TX12 studies
- Garden Grove, CA12 studies
- New York City, NY12 studies
- Miami, FL10 studies
Other studies in Naperville
- Non-Small Cell Lung Cancer15 studies
- Lung Cancer13 studies
- Heart Failure11 studies
- Breast Cancer10 studies
- Prostate Cancer10 studies
- Cardiovascular Disease8 studies
- Pancreatic Cancer6 studies
- Macular Degeneration6 studies
- Geographic Atrophy6 studies
- Colon Cancer6 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Atrial Fibrillation5 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.